Skip to content 
The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation. more
| Time Frame | LFSC | S&P500 |
|---|---|---|
| 1-Week Return | -0.2% | 0.01% |
| 1-Month Return | 19.99% | 3.54% |
| 3-Month Return | 31.31% | 10.58% |
| 6-Month Return | 27.73% | 8.03% |
| 1-Year Return | 80.56% | 20.06% |
| 3-Year Return | 85.16% | 70.98% |
| Stock name | Ticker | Weight |
|---|---|---|
 Travere Therapeutics Inc | TVTX | 7.9% |
 Cogent Biosciences Inc | COGT | 7.25% |
 Spyre Therapeutics Inc | SYRE | 7.15% |
 LivaNova PLC | LIVN | 6.61% |
 Guardant Health Inc | GH | 5.8% |
 Corcept Therapeutics Inc | CORT | 5.34% |
 Mirum Pharmaceuticals Inc | MIRM | 5.14% |
 Billiontoone Inc | BLLN | 4.36% |
 Cytokinetics Inc | CYTK | 4.1% |
 VeraDermics Inc | MANE | 3.51% |
 United Therapeutics Corp | UTHR | 3.43% |
 Trevi Therapeutics Inc | TRVI | 3.37% |
 Savara Inc | SVRA | 3.24% |
 Nektar Therapeutics | NKTR | 2.93% |
 Dianthus Therapeutics Inc | DNTH | 2.76% |
 Axsome Therapeutics Inc | AXSM | 2.51% |
 TransMedics Group Inc | TMDX | 2.39% |
 Viridian Therapeutics Inc | VRDN | 2.13% |
 Corvus Pharmaceuticals Inc | CRVS | 2.12% |
 Palvella Therapeutics Inc | PVLA | 2.06% |
 ICU Medical Inc | ICUI | 2.01% |
 Ceribell Inc | CBLL | 1.37% |
 Twist Bioscience Corp | TWST | 1.32% |
 Bridgebio Pharma Inc | BBIO | 1.32% |
 Hinge Health Inc | HNGE | 1.25% |
 Waystar Holding Corp | WAY | 1.01% |
 Globus Medical Inc | GMED | 0.99% |
 Lumexa Imaging Holdings Inc | LMRI | 0.92% |
 Aveanna Healthcare Holdings Inc | AVAH | 0.82% |
 RadNet Inc | RDNT | 0.78% |
 WaVe Life Sciences Ltd | WVE | 0.76% |
 Korro Bio Inc | KRRO | 0.71% |
 F/m Ultrashort Treasury Inflation-Protected Security TIPS ETF | RBIL | 0.58% |
 Alphatec Holdings Inc | ATEC | 0.58% |
 Insmed Inc | INSM | 0.57% |
 NeoGenomics Inc | NEO | 0.5% |
 Alamar Biosciences Inc | ALMR | 0.2% |
 Definium Therapeutics Inc | DFTX | 0.19% |
 U.S. Bank Money Market Deposit Account 08/01/2031 | U.S..Bank.Money.Market.Deposit.Account.08.01.2031 | 0% |
 Cash & Other | Cash...Other | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
F/m Emerald Life Sciences Innovation ETF (LFSC) share price today is $46.2892.
Yes, Indians can buy shares of F/m Emerald Life Sciences Innovation ETF (LFSC) on Vested. To buy LFSC from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of F/m Emerald Life Sciences Innovation ETF (LFSC) on Vested. You can start investing in F/m Emerald Life Sciences Innovation ETF (LFSC) with a minimum investment of $1.
The 52-week high price of F/m Emerald Life Sciences Innovation ETF (LFSC) is $47.42. The 52-week low price of F/m Emerald Life Sciences Innovation ETF (LFSC) is $24.22.
The stock symbol (or ticker) of F/m Emerald Life Sciences Innovation ETF is LFSC.
Yes, you can setup SIP in F/m Emerald Life Sciences Innovation ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of LFSC on the Vested app.
The expense ratio of F/m Emerald Life Sciences Innovation ETF (LFSC) is .
Link copied 
